ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 55 filers reported holding ESSA PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,675,608 | +4.4% | 1,855,400 | -24.6% | 0.10% | +11.0% |
| Q3 2022 | $4,477,000 | -42.2% | 2,460,000 | 0.0% | 0.09% | -48.9% |
| Q2 2022 | $7,749,000 | -49.0% | 2,460,000 | 0.0% | 0.18% | -43.8% |
| Q1 2022 | $15,203,000 | -56.5% | 2,460,000 | 0.0% | 0.32% | -57.2% |
| Q4 2021 | $34,932,000 | +78.2% | 2,460,000 | +0.4% | 0.74% | +70.7% |
| Q3 2021 | $19,600,000 | -75.1% | 2,450,000 | -10.9% | 0.43% | -79.6% |
| Q2 2021 | $78,568,000 | -4.8% | 2,750,000 | -3.2% | 2.12% | -6.8% |
| Q1 2021 | $82,502,000 | +170.3% | 2,840,000 | +11.0% | 2.28% | +130.0% |
| Q4 2020 | $30,517,000 | +111.8% | 2,558,000 | +22.5% | 0.99% | +48.4% |
| Q3 2020 | $14,406,000 | – | 2,087,800 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,287,094 | $13,247,120 | 1.22% |
| BVF INC/IL | 8,748,629 | $27,033,264 | 0.73% |
| PFM Health Sciences, LP | 4,199,253 | $12,975,692 | 0.61% |
| Bellevue Group AG | 7,898,583 | $24,406,621 | 0.39% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,101,585 | 0.12% |
| Rock Springs Capital Management LP | 677,005 | $2,091,945 | 0.06% |
| Orbimed Advisors | 842,366 | $2,602,911 | 0.06% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,098 | 0.05% |
| Hunting Hill Global Capital, LLC | 10,000 | $30,900 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | $3,221,421 | 0.01% |